Shopping Cart 0
Cart Subtotal
USD 0

Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 175

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 350

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 525
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Ionis Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

Ionis Pharmaceuticals, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Ionis Pharmaceuticals, Inc. (Ionis or the company) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company develops drugs for patients with significant unmet medical needs. Its products pipeline contains two near-term potentially transformative medicines for two different severe and rare diseases. The company develops drugs for the treatment of a wide range of diseases including, cardiovascular disease, clotting disorders, Alzheimer's and Parkinson's disease, and also some rare diseases, such as acromegaly, amyotrophic lateral sclerosis, beta-thalassemia and Huntington's disease. Ionis uses antisense technology in the development of its drugs. The company primarily operates in the US. Ionis is headquartered in Carlsbad, California, the US.

Scope

- Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments

- Intelligence on Ionis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Ionis Pharmaceuticals, Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

Ionis Pharmaceuticals, Inc.: Company Overview 9

Ionis Pharmaceuticals, Inc.: Overview and Key Facts 9

Ionis Pharmaceuticals, Inc.: Overview 9

Ionis Pharmaceuticals, Inc.: Key Facts 9

Ionis Pharmaceuticals, Inc.: Key Employees 11

Ionis Pharmaceuticals, Inc.: Key Employee Biographies 12

Ionis Pharmaceuticals, Inc.: Major Products and Services 15

Ionis Pharmaceuticals, Inc.: Company History 16

Ionis Pharmaceuticals, Inc.: Management Statement 21

Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries 24

Ionis Pharmaceuticals, Inc.: Key Competitors 25

Ionis Pharmaceuticals, Inc.: Company Analysis 26

Ionis Pharmaceuticals, Inc.: Business Description 26

Ionis Pharmaceuticals, Inc.: SWOT Analysis 27

Ionis Pharmaceuticals, Inc.: SWOT Overview 27

Ionis Pharmaceuticals, Inc.: Strengths 27

Ionis Pharmaceuticals, Inc.: Weaknesses 28

Ionis Pharmaceuticals, Inc.: Opportunities 28

Ionis Pharmaceuticals, Inc.: Threats 29

Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity 31

Ionis Pharmaceuticals, Inc.: Financial Deals Overview 31

Ionis Pharmaceuticals, Inc.: Targets and Partners 33

Ionis Pharmaceuticals, Inc.: Top Deals 2014-2018YTD 35

Ionis Pharmaceuticals, Inc.: Advisors 36

Ionis Pharmaceuticals, Inc.: Top Legal Advisors 36

Ionis Pharmaceuticals, Inc.: Top Financial Advisors 36

Ionis Pharmaceuticals, Inc.: Corporate Venturing 37

Ionis Pharmaceuticals, Inc.: Capital Raising 38

Ionis Pharmaceuticals, Inc.: Partnership 39

Ionis Pharmaceuticals, Inc.: Divestments 40

Ionis Pharmaceuticals, Inc.: Private Equity and Ownership 41

Ionis Pharmaceuticals, Inc.: Recent Developments 42

Ionis Pharmaceuticals, Inc.: News and Events Summary 42

Ionis Pharmaceuticals, Inc.: Corporate Governance 45

Ionis Pharmaceuticals, Inc.: Financial Performance 46

Ionis Pharmaceuticals, Inc.: Market Developments 46

Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events 48

Ionis Pharmaceuticals, Inc.: Strategy and Operations 49

Appendix 50

Contact Us 50

Methodology 50

About MarketLine 51


List Of Figure

List of Figures

Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD 2018)

Figure 4: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014-YTD 2018)

Figure 5: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014-YTD 2018)

Figure 6: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014-YTD 2018)

Figure 7: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Figure 8: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)

Figure 9: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014-YTD 2018)

Figure 10: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014-YTD 2018)

Figure 11: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Figure 12: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)


List Of Table

List of Tables

Table 1: Ionis Pharmaceuticals, Inc.: Key Facts

Table 2: Ionis Pharmaceuticals, Inc.: Key Employees

Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries

Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors

Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (TTM )

Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: Ionis Pharmaceuticals, Inc.: Targets and Partners

Table 8: Ionis Pharmaceuticals, Inc.: Top Deals 2014-2018YTD

Table 9: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (USD m)

Table 10: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (USD m)

Table 11: Ionis Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2014-YTD 2018)

Table 12: Ionis Pharmaceuticals, Inc.: Corporate Venturing by Geography (2014-YTD 2018)

Table 13: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2014-YTD 2018)

Table 14: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2014-YTD 2018)

Table 15: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2014-YTD 2018)

Table 16: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2014-YTD 2018)

Table 17: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2014-YTD 2018)

Table 18: Ionis Pharmaceuticals, Inc.: Divestments by Geography (2014-YTD 2018)

Table 19: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Table 20: Ionis Pharmaceuticals, Inc.: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)

Table 21: Ionis Pharmaceuticals, Inc.: News and Events Summary

Table 22: Ionis Pharmaceuticals, Inc.: Corporate Governance

Table 23: Ionis Pharmaceuticals, Inc.: Financial Performance

Table 24: Ionis Pharmaceuticals, Inc.: Market Developments

Table 25: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events

Table 26: Ionis Pharmaceuticals, Inc.: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com